Background Color:
Background Pattern:
Saturday, May 26, 2018
Distinguished Visitors

Professor Tony Culyer, a renowned UK health economist, was hosted for two weeks in 2015 and again in 2016 by PRICELESS SA as a Distinguished Visiting Professor at Wits. 

Professor Culyer, a pioneer in health economics, is Ontario Research Professor of Health Policy and System Design in Toronto and a Professor of Economics at York. He was the founding organiser of the Health Economists’ Study Group and the founding co-editor of the Journal of Health Economics.

Professor Culyer was central to the setting up of the National Institute for Health and Care Excellence (NICE) in the UK and was able to share his experience of its contribution to setting a standard for care as well as the cost implications of such care. He was able to explain how NICE provides evidence-based guidance to the UK public health system on whether to fund particular health interventions, and reflected on the relevance of an institution of this nature for South Africa. 


Dr Neil Soderlund MBBCH (Wits 1989) is a Rhodes Scholar and a PHD health economist. He is a senior adviser in the Sydney office of The Boston Consulting Group (BCG). His work currently focuses on the development and use of information in healthcare, especially with regard to improving patient outcomes and value for money for payers, insurers, and governments. 

Dr Soderlund was awarded a Carnegie-WITS Diaspora Fellowship and was hosted by PRICELESS SA in November 2015. Talks presented were:
 - Integrated needs response outcomes – a way to measure and address the causes of ineffective and mal-distributed healthcare at a state or nation-wide level
 - Measuring Health Outcomes


Paul Revill is a Research Fellow for the Team for Economic Evaluation and Health Technology Assessment (TEEHTA) and is the Theme Lead in Global Health Economic Evaluation at the Centre for Health Economics, University of York, England.

Paul’s research interests revolve around the development of methods and applied economic evaluation to inform resource allocation decisions within healthcare sectors of low- and middle-income countries, particularly in sub-Saharan Africa and related to HIV.  The underlying aim of his work is to ensure that resources committed to healthcare are spent in ways likely to lead to greatest improvements in population health and wellbeing, recognizing the complexities of real world healthcare systems.

  Marion Danis, M.D. is Head of the Section on Ethics and Health Policy in the Department of Bioethics in the Clinical Center of the National Institutes of Health. She also serves as Chief of the Bioethics Consultation Service at the NIH Clinical Center.

Her research currently focuses predominantly on the ethics of health policy, public engagement in priority setting, and efforts to reduce health disparities. She also studies strategies for improving ethics consultation. She has published many articles on patient preferences and the extent to which they are incorporated into practice; and the ethical dilemmas encountered by clinicians and clinical investigators. Her book publications include Ethical Dimensions of Health Policy; Research Ethics Consultations: A Casebook; and Fair Resource Allocation and Rationing at the Bedside.

  Marthe R. Gold MD, MPH is Senior Scholar at the New York Academy of Medicine and Professor Emerita at the Sophie Davis School of Biomedical Education at City College where she served as Chair of its Department of Community Health and Social Medicine from 1997-2014.  The school’s mission is to increase the numbers of minority and economically disadvantaged New Yorkers who enter medicine and practice primary care in physician shortage areas.  A graduate of the Tufts University School of Medicine and the Columbia School of Public Health, Marthe trained in family practice and has worked in rural and urban under-served communities in New York.

Her recent work has been in designing and implementing methods in which to gain a stronger participation from members of the public in areas that are critical to their health, and in contributing to and advocating for analyses that study the economics of population-based interventions.

   Dr. Frank Chaloupka is a research professor in the Division of Health Policy and Administration of the University of Illinois at Chicago School of Public Health. An economist internationally recognized for his study of the economics of tobacco control, he directs IHRP's Health Policy Center. He is the principal investigator of Tobacconomics, economic research that informs tobacco control policy.

His research interests are around the impact of economic, policy and other environmental influences on health behaviors, including tobacco, alcohol and illicit drug use, physical activity, diet, and related outcomes; the economics of tobacco and tobacco control, particularly in developing countries.